• Je něco špatně v tomto záznamu ?

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

L. Naehrlich, A. Orenti, F. Dunlevy, I. Kasmi, S. Harutyunyan, A. Pfleger, S. Keegan, G. Daneau, G. Petrova, D. Tješić-Drinković, P. Yiallouros, A. Bilkova, HV. Olesen, PR. Burgel, T. Parulava, F. Diamantea, A. Párniczky, EF. McKone, M....

. 2021 ; 20 (4) : 566-577. [pub] 20210418

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025462

BACKGROUND: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). METHODS: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. RESULTS: Up to 30 June 2020, 16 countries reported 130 SARS-CoV-2 cases in people with CF, yielding an incidence of 2.70/1000 pwCF. Incidence was higher in lung-transplanted patients (n=23) versus non-transplanted patients (n=107) (8.43 versus 2.36 cases/1000). Incidence was higher in pwCF versus the age-matched general population in the age groups <15, 15-24, and 25-49 years (p<0.001), with similar trends for pwCF with and without lung transplant. Compared to the general population, pwCF (regardless of transplantation status) had significantly higher rates of admission to hospital for all age groups with available data, and higher rates of intensive care, although not statistically significant. Most pwCF recovered (96.2%), however 5 died, of whom 3 were lung transplant recipients. The case fatality rate for pwCF (3.85%, 95% CI: 1.26-8.75) was non-significantly lower than that of the general population (7.46%; p=0.133). CONCLUSIONS: SARS-CoV-2 infection can result in severe illness and death for pwCF, even for younger patients and especially for lung transplant recipients. PwCF should continue to shield from infection and should be prioritized for vaccination.

1 Tsitsishvili Children's Clinic CF Centre Tblisi Georgia

Adult Cystic Fibrosis center Department of Pulmonology Lithuanian University of Health Sciences Kaunas Lithuania

Alexandrovska University Hospital Pediatric Clinic Sofia Bulgaria

Ambulatory Cystic Fibrosis and Other Rare Diseases Center Institute for Maternal and Child Healthcare State University of Medicine and Pharmacy Nicolae Testemitanu Department of Pediatrics Chisinau Republic of Moldova

Belarusian Republic Children's Center of Pulmonology and Cystic Fibrosis Pulmonary Department 3rd City Children's Clinical Hospital Minsk Belarus

Centre for Cystic Fibrosis Hospital de Santa Maria Lisbon Portugal

Centre for Cystic Fibrosis University Children's Hospital Skopje North Macedonia

CF Center University of Cologne Faculty of Medicine Cologne Germany

Cystic Fibrosis Centre University Hospital of Bratislava Bratislava Slovakia

Cystic Fibrosis Regional Reference Center Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico University of Milan Department of Pathophysiology and Transplantation Milan Italy

Cystic Fibrosis Registry of the Czech Republic Prague Czech Republic

Cystic Fibrosis Registry of Turkey Ankara Turkey

Cystic Fibrosis Trust London UK

Department of Clinical Sciences and Community Health Laboratory of Medical Statistics Epidemiology and Biometry G A Maccacaro University of Milan Milan Italy

Department of Paediatric Pulmonology University Children's Hospital Ljubljana University Medical Centre Ljubljana Slovenia

Department of Pediatrics and Adolescent Medicine Cystic Fibrosis Center Aarhus University Hospital Aarhus Denmark

Department of Pediatrics and Adolescent Medicine Division of Pediatric Pulmonology and Allergology Medical University of Graz Graz Austria

Department of Pneumology Children's Clinical University Hospital Rīga Stradinš University Riga Latvia

Department of Pulmonology Hôpital Robert Schuman Luxembourg Luxembourg

Dutch Cystic Fibrosis Foundation Baarn The Netherlands

Dziekanow Paediatric Hospital Cystic Fibrosis Centre Institute of Mother and Child Warsaw Poland

European Cystic Fibrosis Society Karup Denmark

Heim Pál National Pediatric Institute Budapest Hungary

Institute for Translational Medicine University of Pécs Medical School Pécs Hungary

Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences Lviv Ukraine

Laboratory of genetic epidemiology Research Centre for Medical Genetics Moscow Russian Federation

Medical School University of Cyprus Nicosia Cyprus

Mother Thereza Hospital Center Department of Paediatrics Tirana Albania

National Centre for Cystic Fibrosis Mother and Child Health Institute of Serbia Dr Vukan Čupić Belgrade Serbia

Norwegian Resource Centre for Cystic Fibrosis Oslo University Hospital Oslo Norway

Paediatric Pulmonology University Children`s Hospital Zurich Zurich Switzerland

Pediatric Pulmonology and Cystic Fibrosis Unit Virgen de la Arrixaca Clinic University Hospital Murcia Spain

Pulmonary Institute Schneider Children's Medical Center of Israel Petah Tikva Israel

Respiratory Medicine and National Cystic Fibrosis Reference Center Cochin Hospital Assistance Publique Hôpitaux de Paris Université de Paris Institut Cochin INSERM U1016 Paris France

Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

Sciensano Epidemiology and public health Health services research Brussels Belgium

Sismanoglio General Hospital of Attica Adult Cystic Fibrosis Unit Athens Greece

St Vincent's University Hospital and University College Dublin School of Medicine Dublin Ireland

Stockholm CF centre Karolinska University Hospital Karolinska Institutet Stockholm Sweden

Undiagnosed Rare Diseases Interdepartmental Unit National Center Rare Diseases Istituto Superiore di Sanità Rome Italy

Universities of Giessen and Marburg Lung Center German Center of Lung Research Justus Liebig University Giessen Giessen Germany

University Hospital Centre Zagreb Cystic Fibrosis Centre Paediatrics and Adults Zagreb Croatia

Victor Babes University of Medicine and Pharmacy Timisoara National Cystic Fibrosis Centre Timisoara Romania

Yerevan University CF Centre Muratsan Hospital Yerevan Armenia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025462
003      
CZ-PrNML
005      
20211026133801.0
007      
ta
008      
211013s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jcf.2021.03.017 $2 doi
035    __
$a (PubMed)34016559
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Naehrlich, Lutz $u Universities of Giessen and Marburg Lung Center, German Center of Lung Research, Justus-Liebig-University Giessen, Giessen, Germany
245    10
$a Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 / $c L. Naehrlich, A. Orenti, F. Dunlevy, I. Kasmi, S. Harutyunyan, A. Pfleger, S. Keegan, G. Daneau, G. Petrova, D. Tješić-Drinković, P. Yiallouros, A. Bilkova, HV. Olesen, PR. Burgel, T. Parulava, F. Diamantea, A. Párniczky, EF. McKone, M. Mei-Zahav, M. Salvatore, C. Colombo, E. Aleksejeva, K. Malakauskas, M. Schlesser, S. Fustik, O. Turcu, D. Zomer-van Ommen, AS. Wathne, Ł. Woźniacki, L. Pereira, L. Pop, N. Kashirskaya, M. Rodić, H. Kayserova, U. Krivecs, P. Mondejar-Lopez, I. de Monestrol, D. Dogru, H. Makukh, R. Cosgriff, S. van Koningsbruggen-Rietschel, A. Jung, European Cystic Fibrosis COVID project group
520    9_
$a BACKGROUND: Viral infections can cause significant morbidity in cystic fibrosis (CF). The current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic could therefore have a serious impact on the health of people with CF (pwCF). METHODS: We used the 38-country European Cystic Fibrosis Society Patient Registry (ECFSPR) to collect case data about pwCF and SARS-CoV-2 infection. RESULTS: Up to 30 June 2020, 16 countries reported 130 SARS-CoV-2 cases in people with CF, yielding an incidence of 2.70/1000 pwCF. Incidence was higher in lung-transplanted patients (n=23) versus non-transplanted patients (n=107) (8.43 versus 2.36 cases/1000). Incidence was higher in pwCF versus the age-matched general population in the age groups <15, 15-24, and 25-49 years (p<0.001), with similar trends for pwCF with and without lung transplant. Compared to the general population, pwCF (regardless of transplantation status) had significantly higher rates of admission to hospital for all age groups with available data, and higher rates of intensive care, although not statistically significant. Most pwCF recovered (96.2%), however 5 died, of whom 3 were lung transplant recipients. The case fatality rate for pwCF (3.85%, 95% CI: 1.26-8.75) was non-significantly lower than that of the general population (7.46%; p=0.133). CONCLUSIONS: SARS-CoV-2 infection can result in severe illness and death for pwCF, even for younger patients and especially for lung transplant recipients. PwCF should continue to shield from infection and should be prioritized for vaccination.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a COVID-19 $x diagnóza $x epidemiologie $x terapie $7 D000086382
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a péče o pacienty v kritickém stavu $7 D003422
650    _2
$a cystická fibróza $x komplikace $x mortalita $x terapie $7 D003550
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hospitalizace $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a transplantace plic $7 D016040
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a registrace $7 D012042
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Orenti, Annalisa $u Department of Clinical Sciences and Community Health, Laboratory of Medical Statistics, Epidemiology and Biometry G. A. Maccacaro, University of Milan, Milan, Italy
700    1_
$a Dunlevy, Fiona $u European Cystic Fibrosis Society, Karup, Denmark
700    1_
$a Kasmi, Irena $u "Mother Thereza" Hospital Center, Department of Paediatrics, Tirana, Albania
700    1_
$a Harutyunyan, Satenik $u Yerevan University CF Centre, Muratsan Hospital, Yerevan, Armenia
700    1_
$a Pfleger, Andreas $u Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology and Allergology, Medical University of Graz, Graz, Austria
700    1_
$a Keegan, Svetlana $u Belarusian Republic Children's Center of Pulmonology and Cystic Fibrosis, Pulmonary Department, 3rd City Children's Clinical Hospital, Minsk, Belarus
700    1_
$a Daneau, Géraldine $u Sciensano, Epidemiology and public health, Health services research, Brussels, Belgium
700    1_
$a Petrova, Guergana $u Alexandrovska University Hospital, Pediatric Clinic, Sofia, Bulgaria
700    1_
$a Tješić-Drinković, Duška $u University Hospital Centre Zagreb, Cystic Fibrosis Centre - Paediatrics and Adults, Zagreb, Croatia
700    1_
$a Yiallouros, Panayiotis $u Medical School, University of Cyprus, Nicosia, Cyprus
700    1_
$a Bilkova, Alena $u Cystic Fibrosis Registry of the Czech Republic, Prague, Czech Republic
700    1_
$a Olesen, Hanne Vebert $u Department of Pediatrics and Adolescent Medicine, Cystic Fibrosis Center, Aarhus University Hospital, Aarhus, Denmark
700    1_
$a Burgel, Pierre-Régis $u Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Institut Cochin, INSERM U1016, Paris, France
700    1_
$a Parulava, Tsitsino $u I. Tsitsishvili Children's Clinic, CF Centre, Tblisi, Georgia
700    1_
$a Diamantea, Filia $u Sismanoglio General Hospital of Attica, Adult Cystic Fibrosis Unit, Athens, Greece
700    1_
$a Párniczky, Andrea $u Heim Pál National Pediatric Institute, Budapest, Hungary; Institute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary
700    1_
$a McKone, Edward F $u St. Vincent's University Hospital & University College Dublin School of Medicine, Dublin, Ireland
700    1_
$a Mei-Zahav, Meir $u Pulmonary Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
700    1_
$a Salvatore, Marco $u Undiagnosed Rare Diseases Interdepartmental Unit, National Center Rare Diseases, Istituto Superiore di Sanità, Rome, Italy
700    1_
$a Colombo, Carla $u Cystic Fibrosis Regional Reference Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy
700    1_
$a Aleksejeva, Elina $u Department of Pneumology, Children's Clinical University Hospital, Rīga Stradinš University, Riga, Latvia
700    1_
$a Malakauskas, Kestutis $u Adult Cystic Fibrosis center, Department of Pulmonology, Lithuanian University of Health Sciences, Kaunas, Lithuania
700    1_
$a Schlesser, Marc $u Department of Pulmonology, Hôpital Robert Schuman, Luxembourg, Luxembourg
700    1_
$a Fustik, Stojka $u Centre for Cystic Fibrosis, University Children's Hospital, Skopje, North Macedonia
700    1_
$a Turcu, Oxana $u Ambulatory Cystic Fibrosis and Other Rare Diseases Center, Institute for Maternal and Child Healthcare, State University of Medicine and Pharmacy "Nicolae Testemitanu", Department of Pediatrics, Chisinau, Republic of Moldova
700    1_
$a Zomer-van Ommen, Domenique $u Dutch Cystic Fibrosis Foundation (NCFS), Baarn, The Netherlands
700    1_
$a Wathne, Anita Senstad $u Norwegian Resource Centre for Cystic Fibrosis, Oslo University Hospital, Oslo, Norway
700    1_
$a Woźniacki, Łukasz $u Dziekanow Paediatric Hospital, Cystic Fibrosis Centre, Institute of Mother and Child, Warsaw, Poland
700    1_
$a Pereira, Luísa $u Centre for Cystic Fibrosis, Hospital de Santa Maria, Lisbon, Portugal
700    1_
$a Pop, Liviu $u Victor Babes University of Medicine and Pharmacy Timisoara, National Cystic Fibrosis Centre Timisoara, Romania
700    1_
$a Kashirskaya, Nataliya $u Laboratory of genetic epidemiology, "Research Centre for Medical Genetics", Moscow, Russian Federation
700    1_
$a Rodić, Milan $u National Centre for Cystic Fibrosis, Mother and Child Health Institute of Serbia "Dr Vukan Čupić", Belgrade, Serbia
700    1_
$a Kayserova, Hana $u Cystic Fibrosis Centre, University Hospital of Bratislava, Bratislava, Slovakia
700    1_
$a Krivecs, Uro $u Department of Paediatric Pulmonology, University Children's Hospital, Ljubljana University Medical Centre, Ljubljana, Slovenia
700    1_
$a Mondejar-Lopez, Pedro $u Pediatric Pulmonology and Cystic Fibrosis Unit, Virgen de la Arrixaca Clinic University Hospital, Murcia, Spain
700    1_
$a de Monestrol, Isabelle $u Stockholm CF centre, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Dogru, Deniz $u Cystic Fibrosis Registry of Turkey, Ankara, Turkey
700    1_
$a Makukh, Halyna $u Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences, Lviv, Ukraine
700    1_
$a Cosgriff, Rebecca $u Cystic Fibrosis Trust, London, UK
700    1_
$a van Koningsbruggen-Rietschel, Silke $u CF-Center, University of Cologne, Faculty of Medicine, Cologne, Germany
700    1_
$a Jung, Andreas $u Paediatric Pulmonology, University Children`s Hospital Zurich, Zurich, Switzerland
710    2_
$a European Cystic Fibrosis COVID project group
773    0_
$w MED00006892 $t Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society $x 1873-5010 $g Roč. 20, č. 4 (2021), s. 566-577
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34016559 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133807 $b ABA008
999    __
$a ok $b bmc $g 1714493 $s 1145969
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 20 $c 4 $d 566-577 $e 20210418 $i 1873-5010 $m Journal of cystic fibrosis $n J Cyst Fibros $x MED00006892
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...